SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-055870
Filing Date
2021-02-25
Accepted
2021-02-25 08:55:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d326535ds3.htm S-3 227211
2 EX-5.1 d326535dex51.htm EX-5.1 21414
3 EX-23.1 d326535dex231.htm EX-23.1 1761
4 EX-25.1 d326535dex251.htm EX-25.1 55235
5 GRAPHIC g326535g0223122530632.jpg GRAPHIC 3909
6 GRAPHIC g326535g02a55.jpg GRAPHIC 40819
  Complete submission text file 0001193125-21-055870.txt   368203
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-253485 | Film No.: 21676671
SIC: 2834 Pharmaceutical Preparations